Disc Medicine, Inc.
IRON
Rangering i aksjer
#4958
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Aksjekurs
$75.39
Sist synkronisert: 2026-10-22
Markedsverdi
$2.89B
Endring (1 dag)
-0.80%
Endring (1 år)
-9.92%
Land
US
Handel Disc Medicine, Inc. (IRON)
Kategori
Healthcare
EPS for Disc Medicine, Inc. (IRON)
EPS per June 2026 TTM: $-6.60
Ifølge de siste økonomiske rapportene og aksjekursen til Disc Medicine, Inc. er selskapets nåværende EPS (TTM) $-6.60. Ved slutten av 2024 hadde selskapet en EPS på $-3.96, en økning sammenlignet med EPS-en i 2023 som var $-3.42.
EPS-historikk for Disc Medicine, Inc. fra 2020 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $-6.60 | 9.82% |
| 2025 | $-6.01 | 51.77% |
| 2024 | $-3.96 | 15.79% |
| 2023 | $-3.42 | -92.41% |
| 2022 | $-45.05 | 0.38% |
| 2021 | $-44.88 | 66.10% |
| 2020 | $-27.02 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $17.32 | -362.42% |
US
|
|
| $-7.98 | 20.91% |
US
|
|
| $-5.29 | -19.85% |
AU
|
|
| $12.97 | -296.53% |
BE
|
|
| $27.74 | -520.30% |
NL
|
